BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

XtalPi and CK Life Sciences Partner to Develop AI-Based Cancer Diagnostic Models

With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...

November 06, 2023 | News

Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually...

November 03, 2023 | News

CStone Partners with 3SBio for Nofazinlimab in China

CStone to grant 3SBio exclusive rights for the development, registration, manufacturing, and commercialization of nofazinlimab (anti-PD-1 antibody) in ma...

November 02, 2023 | News

Rational Vaccines and Shenzhen Mellow Hope Partner on Herpes Vaccines in China

Rational Vaccines (RVx) and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (MH) announced they have reached an agreement to jointly develop, manufacture, ...

October 31, 2023 | News

First Patient Enrolled in Phase III Trial of Boan Biotech's Nivolumab

Nivolumab is a monoclonal antibody that can enhance the immune response of T cells against tumors by preventing the programmed cell death 1 (PD-1) receptor...

October 31, 2023 | News

Merck Expands Oncology Pipeline with Hengrui Partnership for PARP1 Inhibitor and ADC

Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...

October 31, 2023 | News

Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia

Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...

October 27, 2023 | News

Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China

This strategic partnership will enable Fapon to engage in the research, development, manufacturing, and commercialization of PSP raw materials and chemilum...

October 27, 2023 | News

Life Molecular Imaging and Sinotau Gain Regulatory Approval for Neuraceq® in China

Life Molecular Imaging (LMI) and Sinotau Pharmaceutical Group are pleased to announce Neuraceq® (with Chinese trade name 欧韦宁®, florbetaben F-...

October 25, 2023 | News

Bio4t2 Trials CAR-T for Solid Tumors Without Lymphodepletion

The PrismCore platform generates CAR-T that recognizes overexpressed self-antigens on solid tumors. Bio-Engine adapts the CAR-T to transiently recogni...

October 18, 2023 | News

CANbridge Reaches Full Enrollment in Phase 2 Trial for Gaucher Disease in China

Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...

October 17, 2023 | News

WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing

WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...

October 17, 2023 | News

Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...

October 16, 2023 | News

CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...

October 13, 2023 | News

Stay Connected